/PRNewswire/ Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval of its.
With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.
While devices that stimulate the brain invasively have generally been available since 2002, and devices that do so non-invasively have been available since 2013, in recent years, the.
MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ Boston Scientific Corporation generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis,.
MARLBOROUGH, Mass., Jul. 11, 2023 Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration approval for the Vercise™ Neural Navigator 5.